The markets closed flat with the Dow easing a point to 15,520 ahead of the Federal Reserve's statement tomorrow. Nasdaq gained 17 points to 3616.
On the upside
Second quarter earnings fell for R.R. Donnelley & Sons (Nasdaq: RRD) but the results surpassed analyst expectations.
The Food and Drug Administration will review Vanda Pharmaceuticals' (Nasdaq: VNDA) sleep disorder treatment tasimelteon on quicker schedule.
Pitney Bowes (Nasdaq: PBI) fell to a loss for the second quarter but the company announced plans to sell it management services unit for $400 million to Apollo Global Management.
On the downside
Turquoise Hill Resources (NYSE: TRQ) continued falling after announcing additional delays to the Oyu Tolgoi project.
Second quarter earnings plunged for Xylem (NYSE: XYL) to fall short of analyst expectations prompting the company to cut its full year earnings outlook.
U. S. Steel (NYSE: X) fell to a loss for the second quarter.
In the broad market, declining issues barely edged out advancers by a slim margin on the NYSE while advancers outpaced decliners by nearly 10 to 9 on Nasdaq. The broader S&P 500 held stead at 1685.